AXA vs Pfizer: Founders, CEOs and History
AXA was founded in 1817 by Jacques-Théodore le Carpentier, Claude Bébéar and is led by Thomas Buberl. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.
Company facts
Founders
AXA
Jacques-Théodore le Carpentier
Little is recorded about le Carpentier beyond the founding act itself. In 1817 he and 17 other property owners in Rouen created the Compagnie d'Assurances Mutuelles contre l'Incendie for the departments of the Seine and the Eure, covering their own buildings a…
Claude Bébéar
Claude Bébéar built modern AXA. After joining in 1958 he spent 17 years inside the business, including 1964 to 1966 in Canada creating the life insurance arm of the group subsidiary Provinces Unies, before becoming chief executive in 1975 following Sahut d'Iza…
Pfizer
Charles Pfizer
Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.
Charles Erhart
Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…
CEOs and their tenures
AXA
- Claude Bébéar1975–2000
Chairman and CEO
Bébéar turned a Normandy mutual into a global insurer between 1975 and 2000. He took control of the Drouot Group in 1982, bought Présence in 1986, merged with Compagnie du Midi in 1988, took control of The Equitable in the United States in 1991, National Mutua…
Source - Henri de Castries2000–2016
Chairman and CEO
De Castries ran AXA from May 2000 to September 2016, through the dot-com collapse, the 2008 financial crisis and the euro-area debt crisis, without state support.
Source - Thomas Buberl2016–present
Chief Executive Officer
Buberl became chief executive in September 2016 and refocused AXA on insurance underwriting.
Source
Pfizer
- Ian Read2010–2018
Chief Executive Officer
He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.
Source - Albert Bourla2019–present
Chairman and Chief Executive Officer
A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
Source - Dave Denton2022–2026
Chief Financial Officer
As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.
Source - Chris Boshoff2025–present
Chief Scientific Officer and President, Research & Development
He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.
Source - Cecile Guegan2026–present
Interim Chief Financial Officer
She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.
Source
Timeline: AXA and Pfizer side by side
1817AXA
Founding of the Compagnie d'Assurances Mutuelles contre l'Incendie
Jacques-Théodore le Carpentier and 17 other property owners in Rouen set up a mutual fire insurance company, the earliest predecessor of AXA. It stayed a Normandy mutual, later called Ancienne Mutuelle, for more than a century.
1849Pfizer
Pfizer Founded
Charles Pfizer and Charles Erhart founded the company in Brooklyn.
1944Pfizer
Penicillin Scale-Up
Pfizer helped industrialize penicillin production during World War II.
1975AXA
Claude Bébéar becomes chief executive
Bébéar, recruited in 1958 by André Sahut d'Izarn, took over the Anciennes Mutuelles group in 1975 after Sahut d'Izarn's death and the settlement of a strike that had paralysed the company in April 1974.
1982AXA
Takeover of the Drouot Group
Bébéar took control of the Drouot Group, then the leading private French insurance group, and became its chairman alongside his role at Mutuelles Unies.
1985AXA
Creation of the AXA name
The group adopted the invented name AXA, short and pronounceable in any language, and Bébéar moved from running the insurance companies to chairing the group.
1986AXA
Acquisition of the Présence Group
AXA bought the Présence Group in April 1986, continuing the consolidation of French insurers.
1988AXA
Merger with Compagnie du Midi
The merger with Compagnie du Midi made AXA the second-largest French insurance group behind UAP and brought Equity and Law, then the sixth-largest life insurer in the United Kingdom. Bébéar was elected Manager of the Year the same year.
1991AXA
Control of The Equitable in the United States
After a failed attempt to buy Farmers, AXA agreed in July 1991 to demutualise and take control of The Equitable, then the fifth-largest life insurer in the United States, which also brought Alliance Capital Management.
1996AXA
Acquisition of UAP
AXA bought UAP, a French insurer twice its size, doubling its French business and reaching critical mass in the United Kingdom, Belgium and Germany. The merger took effect in 1997.
1998Pfizer
Viagra Approved
The FDA approved Viagra in 1998.
1999AXA
Guardian Royal Exchange and Nippon Dantai
Guardian Royal Exchange joined AXA in early 1999, adding scale in United Kingdom property, casualty and health insurance, and AXA took control of Nippon Dantai, then the thirteenth-largest life insurer in Japan.
2000Pfizer
Warner-Lambert Deal
Pfizer acquired Warner-Lambert, adding Lipitor.
2006AXA
Acquisition of Winterthur
AXA agreed to buy Winterthur from Credit Suisse for ~$14.8 billion (CHF 12.3 billion), about $8.93 billion (EUR 7.9 billion) in cash, strengthening its position in Switzerland, Germany and central and eastern Europe.
2011AXA
Sale of AXA Canada
AXA sold its Canadian operations to Intact Financial Corp. for ~$1.87 billion (C$2.6 billion) as part of a portfolio review.
2018AXA
Acquisition of XL Group
AXA bought XL Group for $15.3 billion in cash, shifting the group toward commercial property and casualty lines and creating the AXA XL platform.
2019Pfizer
Albert Bourla becomes CEO
Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
2020Pfizer
BioNTech COVID Vaccine Partnership
Pfizer and BioNTech brought Comirnaty through emergency authorization.
2023Pfizer
Seagen Acquisition
Pfizer completed the $43 billion Seagen acquisition.
2024AXA
Launch of the Unlock the Future plan
With its 2023 results in February 2024 AXA presented a 2024 to 2026 plan targeting underlying earnings per share growth of 6% to 8% a year, an underlying return on equity of 14% to 16% and a new capital management policy.
2025AXA
Sale of AXA Investment Managers to BNP Paribas
AXA completed the sale of AXA Investment Managers to BNP Paribas Cardif on July 1, 2025 for ~$5.76 billion (EUR 5.1 billion) in cash, a total transaction value of ~$6.1 billion (EUR 5.4 billion), and signed a long-term agreement for BNP Paribas to manage a lar…
2025AXA
Death of founder Claude Bébéar
AXA announced on November 4, 2025 that Claude Bébéar, its founder and Honorary Chairman, had died at the age of 90. He ran the group from 1975 to 2000 and created the AXA name in 1985.
2025Pfizer
Chris Boshoff Becomes CSO
Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
2025Pfizer
Metsera Acquisition
Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.
2025Pfizer
FY2025 Revenue Base
Pfizer reported $62.579 billion of FY2025 revenue.
2026Pfizer
Innovent Oncology Collaboration
Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.
Acquisitions
AXA
- Prima Assicurazioni (51% stake)2025Undisclosed
- Laya Healthcare2023Undisclosed
- XL Group2018$15.3B
- Winterthur2006$10B
- UAP (Union des Assurances de Paris)1996$7.8B
- The Equitable (US)1991$1B
Pfizer
- Metsera, Inc.2025$7B
- Seagen Inc.2023$43B
- Medivation Inc.2016$14B
- Wyeth2009$68B
- Pharmacia Corporation2003$60B
- Warner-Lambert Company2000$111B
Questions about AXA vs Pfizer
Who is the CEO of AXA SA and Pfizer Inc.?
AXA SA is led by Thomas Buberl and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AXA SA founded vs Pfizer Inc.?
AXA SA was founded in 1817 — 32 years before Pfizer Inc., which was founded in 1849. AXA SA's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Pfizer Inc..
How many employees does AXA SA have compared to Pfizer Inc.?
AXA SA employs approximately 156,000 people, while Pfizer Inc. employs approximately 75,000. AXA SA has the larger workforce at 156,000 employees, compared to Pfizer Inc.'s 75,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AXA SA and Pfizer Inc. headquartered?
AXA SA is headquartered in France and Pfizer Inc. is headquartered in United States. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded AXA SA and Pfizer Inc.?
AXA SA was founded by Jacques-Théodore le Carpentier, Claude Bébéar. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.
Which company has a longer operating history — AXA SA or Pfizer Inc.?
AXA SA has been operating for approximately 209 years, making it the more established of the two companies. Pfizer Inc. has been in operation for around 177 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AXA vs Pfizer overview